These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9046073)

  • 1. Imaging of delta opioid receptors in human brain by N1'-([11C]methyl)naltrindole and PET.
    Madar I; Lever JR; Kinter CM; Scheffel U; Ravert HT; Musachio JL; Mathews WB; Dannals RF; Frost JJ
    Synapse; 1996 Sep; 24(1):19-28. PubMed ID: 9046073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo binding of N1'-([11C]methyl)naltrindole to delta-opioid receptors in mouse brain.
    Lever JR; Scheffel U; Kinter CM; Ravert HT; Dannals RF; Wagner HN; Frost JJ
    Eur J Pharmacol; 1992 Jun; 216(3):459-60. PubMed ID: 1330587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of delta-opioid receptors in human brain with N1'-([11C]methyl) naltrindole and positron emission tomography.
    Smith JS; Zubieta JK; Price JC; Flesher JE; Madar I; Lever JR; Kinter CM; Dannals RF; Frost JJ
    J Cereb Blood Flow Metab; 1999 Sep; 19(9):956-66. PubMed ID: 10478647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects.
    Weerts EM; Kim YK; Wand GS; Dannals RF; Lee JS; Frost JJ; McCaul ME
    Neuropsychopharmacology; 2008 Feb; 33(3):653-65. PubMed ID: 17487229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N1'-fluoroethyl-naltrindole (BU97001) and N1'-fluoroethyl-(14-formylamino)-naltrindole (BU97018) potential delta-opioid receptor PET ligands.
    Tyacke RJ; Robinson ES; Schnabel R; Lewis JW; Husbands SM; Nutt DJ; Hudson AL
    Nucl Med Biol; 2002 May; 29(4):455-62. PubMed ID: 12031880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography.
    Madar I; Lesser RP; Krauss G; Zubieta JK; Lever JR; Kinter CM; Ravert HT; Musachio JL; Mathews WB; Dannals RF; Frost JJ
    Ann Neurol; 1997 Mar; 41(3):358-67. PubMed ID: 9066357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo labeling of delta opioid receptors in mouse brain by [3H]benzylidenenaltrexone, a ligand selective for the delta 1 subtype.
    Lever JR; Stathis M; Kinter CM; Scheffel U
    Life Sci; 1996; 58(21):PL331-6. PubMed ID: 8637403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging delta- and mu-opioid receptors by PET in lung carcinoma patients.
    Madar I; Bencherif B; Lever J; Heitmiller RF; Yang SC; Brock M; Brahmer J; Ravert H; Dannals R; Frost JJ
    J Nucl Med; 2007 Feb; 48(2):207-13. PubMed ID: 17268016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of opioid receptor antagonist [3H]-LY255582 binding sites in mouse brain: comparison with the distribution of mu, delta and kappa binding sites.
    Gackenheimer SL; Suter TM; Pintar JE; Quimby SJ; Wheeler WJ; Mitch CH; Gehlert DR; Statnick MA
    Neuropeptides; 2005 Dec; 39(6):559-67. PubMed ID: 16289278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET imaging of human cardiac opioid receptors.
    Villemagne PS; Dannals RF; Ravert HT; Frost JJ
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1385-8. PubMed ID: 12271423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity.
    Fang L; Knapp RJ; Horvath R; Matsunaga TO; Haaseth RC; Hruby VJ; Porreca F; Yamamura HI
    J Pharmacol Exp Ther; 1994 Feb; 268(2):836-46. PubMed ID: 8113996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An updated synthesis of N
    Kaur T; Brooks AF; Hockley BG; Torres J; Henderson BD; Scott PJH; Shao X
    J Labelled Comp Radiopharm; 2021 Apr; 64(4):187-193. PubMed ID: 33274468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alkylation of opioid receptors by 5'-naltrindole-isothiocyanate injected into the nucleus accumbens of rats: receptor selectivity and anatomical diffusion.
    Martin TJ; McIntosh S; Smith JE
    Synapse; 2006 Oct; 60(5):384-91. PubMed ID: 16847946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. delta-Opioid receptor: the third extracellular loop determines naltrindole selectivity.
    Li X; Varga EV; Stropova D; Zalewska T; Malatynska E; Knapp RJ; Roeske WR; Yamamura HI
    Eur J Pharmacol; 1996 Apr; 300(1-2):R1-2. PubMed ID: 8741185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of a ligand targeting the μ and δ opioid receptors for drug delivery to lung cancer.
    Li G; Low PS
    Bioorg Med Chem Lett; 2017 May; 27(9):2074-2078. PubMed ID: 28291693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of N-substituted quinolinimides, as potential ligands for in vivo imaging studies of delta-opioid receptors.
    Bourdier T; Poisnel G; Dhilly M; Delamare J; Henry J; Debruyne D; Barré L
    Bioconjug Chem; 2007; 18(2):538-48. PubMed ID: 17341107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of serotonin 5-HT2 receptors in living human brain by positron emission tomography using N1-([11C]-methyl)-2-Br-LSD.
    Wong DF; Lever JR; Hartig PR; Dannals RF; Villemagne V; Hoffman BJ; Wilson AA; Ravert HT; Links JM; Scheffel U
    Synapse; 1987; 1(5):393-8. PubMed ID: 2905532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
    Solinas M; Goldberg SR
    Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.